In particular, the alteration of G13 signaling seen in all but one cancer-related Lphn3 variants indicates that non-synonymous single amino acid substitutions targeting the GAIN domain can singlehandedly modify its canonical signaling properties, potentially establishing a successful strategy to reprogram the adhesion-sensing capabilities of cancer cells. Here, ADGRL3 is linked to cancer.